nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—FDPS—nephron tubule—kidney cancer	0.00795	0.19	CbGeAlD
Pamidronate—FDPS—renal system—kidney cancer	0.00723	0.172	CbGeAlD
Pamidronate—FDPS—kidney—kidney cancer	0.00699	0.167	CbGeAlD
Pamidronate—FDPS—cortex of kidney—kidney cancer	0.00681	0.162	CbGeAlD
Pamidronate—FDPS—gonad—kidney cancer	0.00648	0.155	CbGeAlD
Pamidronate—FDPS—cardiac atrium—kidney cancer	0.00647	0.154	CbGeAlD
Pamidronate—Zoledronate—CA2—kidney cancer	0.00565	0.521	CrCbGaD
Pamidronate—Risedronate—PTGS2—kidney cancer	0.00275	0.253	CrCbGaD
Pamidronate—Clodronate—PTGS2—kidney cancer	0.00245	0.226	CrCbGaD
Pamidronate—Loss of consciousness—Paclitaxel—kidney cancer	0.000398	0.00042	CcSEcCtD
Pamidronate—Constipation—Vincristine—kidney cancer	0.000398	0.00042	CcSEcCtD
Pamidronate—Pain—Vincristine—kidney cancer	0.000398	0.00042	CcSEcCtD
Pamidronate—Osteoarthritis—Doxorubicin—kidney cancer	0.000397	0.00042	CcSEcCtD
Pamidronate—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000397	0.00042	CcSEcCtD
Pamidronate—Paraesthesia—Gemcitabine—kidney cancer	0.000396	0.000418	CcSEcCtD
Pamidronate—Flushing—Capecitabine—kidney cancer	0.000396	0.000418	CcSEcCtD
Pamidronate—Cardiac disorder—Capecitabine—kidney cancer	0.000396	0.000418	CcSEcCtD
Pamidronate—Cough—Paclitaxel—kidney cancer	0.000395	0.000417	CcSEcCtD
Pamidronate—Asthenia—Sunitinib—kidney cancer	0.000394	0.000416	CcSEcCtD
Pamidronate—Dyspnoea—Gemcitabine—kidney cancer	0.000393	0.000415	CcSEcCtD
Pamidronate—Nausea—Vinblastine—kidney cancer	0.000392	0.000414	CcSEcCtD
Pamidronate—Somnolence—Gemcitabine—kidney cancer	0.000392	0.000414	CcSEcCtD
Pamidronate—Convulsion—Paclitaxel—kidney cancer	0.000392	0.000414	CcSEcCtD
Pamidronate—Nausea—Everolimus—kidney cancer	0.000391	0.000413	CcSEcCtD
Pamidronate—Diarrhoea—Sorafenib—kidney cancer	0.000391	0.000413	CcSEcCtD
Pamidronate—Hypertension—Paclitaxel—kidney cancer	0.000391	0.000412	CcSEcCtD
Pamidronate—Pruritus—Sunitinib—kidney cancer	0.000389	0.000411	CcSEcCtD
Pamidronate—Angiopathy—Capecitabine—kidney cancer	0.000387	0.000408	CcSEcCtD
Pamidronate—Immune system disorder—Capecitabine—kidney cancer	0.000385	0.000407	CcSEcCtD
Pamidronate—Myalgia—Paclitaxel—kidney cancer	0.000385	0.000407	CcSEcCtD
Pamidronate—Arthralgia—Paclitaxel—kidney cancer	0.000385	0.000407	CcSEcCtD
Pamidronate—Mediastinal disorder—Capecitabine—kidney cancer	0.000384	0.000406	CcSEcCtD
Pamidronate—Anxiety—Paclitaxel—kidney cancer	0.000384	0.000405	CcSEcCtD
Pamidronate—Decreased appetite—Gemcitabine—kidney cancer	0.000383	0.000405	CcSEcCtD
Pamidronate—Hypersensitivity—Dactinomycin—kidney cancer	0.000383	0.000405	CcSEcCtD
Pamidronate—Chills—Capecitabine—kidney cancer	0.000383	0.000404	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000381	0.000402	CcSEcCtD
Pamidronate—Discomfort—Paclitaxel—kidney cancer	0.000381	0.000402	CcSEcCtD
Pamidronate—Fatigue—Gemcitabine—kidney cancer	0.00038	0.000401	CcSEcCtD
Pamidronate—Gastrointestinal pain—Vincristine—kidney cancer	0.00038	0.000401	CcSEcCtD
Pamidronate—Dizziness—Sorafenib—kidney cancer	0.000378	0.000399	CcSEcCtD
Pamidronate—Pain—Gemcitabine—kidney cancer	0.000377	0.000398	CcSEcCtD
Pamidronate—Constipation—Gemcitabine—kidney cancer	0.000377	0.000398	CcSEcCtD
Pamidronate—Nausea—Erlotinib—kidney cancer	0.000377	0.000398	CcSEcCtD
Pamidronate—Alopecia—Capecitabine—kidney cancer	0.000377	0.000398	CcSEcCtD
Pamidronate—Diarrhoea—Sunitinib—kidney cancer	0.000376	0.000397	CcSEcCtD
Pamidronate—Asthenia—Dactinomycin—kidney cancer	0.000373	0.000394	CcSEcCtD
Pamidronate—Confusional state—Paclitaxel—kidney cancer	0.000372	0.000393	CcSEcCtD
Pamidronate—Blood creatinine increased—Doxorubicin—kidney cancer	0.000372	0.000393	CcSEcCtD
Pamidronate—Erythema—Capecitabine—kidney cancer	0.000371	0.000392	CcSEcCtD
Pamidronate—Malnutrition—Capecitabine—kidney cancer	0.000371	0.000392	CcSEcCtD
Pamidronate—Oedema—Paclitaxel—kidney cancer	0.000369	0.00039	CcSEcCtD
Pamidronate—Anaphylactic shock—Paclitaxel—kidney cancer	0.000369	0.00039	CcSEcCtD
Pamidronate—Abdominal pain—Vincristine—kidney cancer	0.000367	0.000388	CcSEcCtD
Pamidronate—Body temperature increased—Vincristine—kidney cancer	0.000367	0.000388	CcSEcCtD
Pamidronate—Liver function test abnormal—Doxorubicin—kidney cancer	0.000367	0.000387	CcSEcCtD
Pamidronate—Infection—Paclitaxel—kidney cancer	0.000367	0.000387	CcSEcCtD
Pamidronate—Dysgeusia—Capecitabine—kidney cancer	0.000364	0.000384	CcSEcCtD
Pamidronate—Dizziness—Sunitinib—kidney cancer	0.000363	0.000384	CcSEcCtD
Pamidronate—Feeling abnormal—Gemcitabine—kidney cancer	0.000363	0.000384	CcSEcCtD
Pamidronate—Shock—Paclitaxel—kidney cancer	0.000363	0.000383	CcSEcCtD
Pamidronate—Vomiting—Sorafenib—kidney cancer	0.000363	0.000383	CcSEcCtD
Pamidronate—Nervous system disorder—Paclitaxel—kidney cancer	0.000362	0.000382	CcSEcCtD
Pamidronate—Hypokalaemia—Doxorubicin—kidney cancer	0.000362	0.000382	CcSEcCtD
Pamidronate—Thrombocytopenia—Paclitaxel—kidney cancer	0.000362	0.000382	CcSEcCtD
Pamidronate—Tachycardia—Paclitaxel—kidney cancer	0.00036	0.00038	CcSEcCtD
Pamidronate—Rash—Sorafenib—kidney cancer	0.00036	0.00038	CcSEcCtD
Pamidronate—Dermatitis—Sorafenib—kidney cancer	0.00036	0.00038	CcSEcCtD
Pamidronate—Back pain—Capecitabine—kidney cancer	0.000359	0.000379	CcSEcCtD
Pamidronate—Headache—Sorafenib—kidney cancer	0.000358	0.000378	CcSEcCtD
Pamidronate—Muscle spasms—Capecitabine—kidney cancer	0.000357	0.000377	CcSEcCtD
Pamidronate—Hyperhidrosis—Paclitaxel—kidney cancer	0.000357	0.000377	CcSEcCtD
Pamidronate—Diarrhoea—Dactinomycin—kidney cancer	0.000356	0.000376	CcSEcCtD
Pamidronate—Nasopharyngitis—Doxorubicin—kidney cancer	0.000355	0.000375	CcSEcCtD
Pamidronate—Anorexia—Paclitaxel—kidney cancer	0.000352	0.000372	CcSEcCtD
Pamidronate—Gastritis—Doxorubicin—kidney cancer	0.000352	0.000371	CcSEcCtD
Pamidronate—Vomiting—Sunitinib—kidney cancer	0.000349	0.000369	CcSEcCtD
Pamidronate—Body temperature increased—Gemcitabine—kidney cancer	0.000349	0.000368	CcSEcCtD
Pamidronate—Rash—Sunitinib—kidney cancer	0.000347	0.000366	CcSEcCtD
Pamidronate—Dermatitis—Sunitinib—kidney cancer	0.000346	0.000366	CcSEcCtD
Pamidronate—Hypotension—Paclitaxel—kidney cancer	0.000345	0.000364	CcSEcCtD
Pamidronate—Ill-defined disorder—Capecitabine—kidney cancer	0.000344	0.000364	CcSEcCtD
Pamidronate—Headache—Sunitinib—kidney cancer	0.000344	0.000363	CcSEcCtD
Pamidronate—Influenza—Doxorubicin—kidney cancer	0.000343	0.000363	CcSEcCtD
Pamidronate—Anaemia—Capecitabine—kidney cancer	0.000343	0.000362	CcSEcCtD
Pamidronate—Hypersensitivity—Vincristine—kidney cancer	0.000342	0.000362	CcSEcCtD
Pamidronate—Nausea—Sorafenib—kidney cancer	0.000339	0.000358	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000336	0.000355	CcSEcCtD
Pamidronate—Malaise—Capecitabine—kidney cancer	0.000335	0.000353	CcSEcCtD
Pamidronate—Insomnia—Paclitaxel—kidney cancer	0.000334	0.000353	CcSEcCtD
Pamidronate—Asthenia—Vincristine—kidney cancer	0.000334	0.000352	CcSEcCtD
Pamidronate—Syncope—Capecitabine—kidney cancer	0.000333	0.000351	CcSEcCtD
Pamidronate—Leukopenia—Capecitabine—kidney cancer	0.000332	0.000351	CcSEcCtD
Pamidronate—Paraesthesia—Paclitaxel—kidney cancer	0.000332	0.00035	CcSEcCtD
Pamidronate—Vomiting—Dactinomycin—kidney cancer	0.000331	0.000349	CcSEcCtD
Pamidronate—Dyspnoea—Paclitaxel—kidney cancer	0.000329	0.000348	CcSEcCtD
Pamidronate—Somnolence—Paclitaxel—kidney cancer	0.000328	0.000347	CcSEcCtD
Pamidronate—Rash—Dactinomycin—kidney cancer	0.000328	0.000346	CcSEcCtD
Pamidronate—Nausea—Sunitinib—kidney cancer	0.000326	0.000345	CcSEcCtD
Pamidronate—Loss of consciousness—Capecitabine—kidney cancer	0.000326	0.000344	CcSEcCtD
Pamidronate—Dyspepsia—Paclitaxel—kidney cancer	0.000325	0.000343	CcSEcCtD
Pamidronate—Cough—Capecitabine—kidney cancer	0.000324	0.000342	CcSEcCtD
Pamidronate—Neutropenia—Doxorubicin—kidney cancer	0.000321	0.000339	CcSEcCtD
Pamidronate—Decreased appetite—Paclitaxel—kidney cancer	0.000321	0.000339	CcSEcCtD
Pamidronate—Hypertension—Capecitabine—kidney cancer	0.000321	0.000338	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000319	0.000337	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000319	0.000337	CcSEcCtD
Pamidronate—Fatigue—Paclitaxel—kidney cancer	0.000318	0.000336	CcSEcCtD
Pamidronate—Diarrhoea—Vincristine—kidney cancer	0.000318	0.000336	CcSEcCtD
Pamidronate—Asthenia—Gemcitabine—kidney cancer	0.000316	0.000334	CcSEcCtD
Pamidronate—Myalgia—Capecitabine—kidney cancer	0.000316	0.000334	CcSEcCtD
Pamidronate—Arthralgia—Capecitabine—kidney cancer	0.000316	0.000334	CcSEcCtD
Pamidronate—Constipation—Paclitaxel—kidney cancer	0.000316	0.000333	CcSEcCtD
Pamidronate—Pain—Paclitaxel—kidney cancer	0.000316	0.000333	CcSEcCtD
Pamidronate—Anxiety—Capecitabine—kidney cancer	0.000315	0.000333	CcSEcCtD
Pamidronate—Discomfort—Capecitabine—kidney cancer	0.000312	0.00033	CcSEcCtD
Pamidronate—Pruritus—Gemcitabine—kidney cancer	0.000312	0.000329	CcSEcCtD
Pamidronate—Nausea—Dactinomycin—kidney cancer	0.000309	0.000326	CcSEcCtD
Pamidronate—Pneumonia—Doxorubicin—kidney cancer	0.000308	0.000325	CcSEcCtD
Pamidronate—Dizziness—Vincristine—kidney cancer	0.000307	0.000325	CcSEcCtD
Pamidronate—Infestation NOS—Doxorubicin—kidney cancer	0.000306	0.000323	CcSEcCtD
Pamidronate—Infestation—Doxorubicin—kidney cancer	0.000306	0.000323	CcSEcCtD
Pamidronate—Confusional state—Capecitabine—kidney cancer	0.000306	0.000323	CcSEcCtD
Pamidronate—Feeling abnormal—Paclitaxel—kidney cancer	0.000304	0.000321	CcSEcCtD
Pamidronate—Oedema—Capecitabine—kidney cancer	0.000303	0.00032	CcSEcCtD
Pamidronate—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000302	0.000319	CcSEcCtD
Pamidronate—Diarrhoea—Gemcitabine—kidney cancer	0.000302	0.000319	CcSEcCtD
Pamidronate—Renal failure—Doxorubicin—kidney cancer	0.000301	0.000318	CcSEcCtD
Pamidronate—Infection—Capecitabine—kidney cancer	0.000301	0.000318	CcSEcCtD
Pamidronate—Stomatitis—Doxorubicin—kidney cancer	0.000299	0.000315	CcSEcCtD
Pamidronate—Shock—Capecitabine—kidney cancer	0.000298	0.000315	CcSEcCtD
Pamidronate—Urinary tract infection—Doxorubicin—kidney cancer	0.000298	0.000314	CcSEcCtD
Pamidronate—Conjunctivitis—Doxorubicin—kidney cancer	0.000298	0.000314	CcSEcCtD
Pamidronate—Nervous system disorder—Capecitabine—kidney cancer	0.000297	0.000314	CcSEcCtD
Pamidronate—Thrombocytopenia—Capecitabine—kidney cancer	0.000297	0.000313	CcSEcCtD
Pamidronate—Tachycardia—Capecitabine—kidney cancer	0.000296	0.000312	CcSEcCtD
Pamidronate—Vomiting—Vincristine—kidney cancer	0.000296	0.000312	CcSEcCtD
Pamidronate—Rash—Vincristine—kidney cancer	0.000293	0.000309	CcSEcCtD
Pamidronate—Hyperhidrosis—Capecitabine—kidney cancer	0.000293	0.000309	CcSEcCtD
Pamidronate—Dermatitis—Vincristine—kidney cancer	0.000293	0.000309	CcSEcCtD
Pamidronate—Haematuria—Doxorubicin—kidney cancer	0.000292	0.000308	CcSEcCtD
Pamidronate—Abdominal pain—Paclitaxel—kidney cancer	0.000292	0.000308	CcSEcCtD
Pamidronate—Body temperature increased—Paclitaxel—kidney cancer	0.000292	0.000308	CcSEcCtD
Pamidronate—Headache—Vincristine—kidney cancer	0.000291	0.000307	CcSEcCtD
Pamidronate—Anorexia—Capecitabine—kidney cancer	0.000289	0.000305	CcSEcCtD
Pamidronate—Sinusitis—Doxorubicin—kidney cancer	0.000287	0.000303	CcSEcCtD
Pamidronate—Agranulocytosis—Doxorubicin—kidney cancer	0.000286	0.000302	CcSEcCtD
Pamidronate—Hypotension—Capecitabine—kidney cancer	0.000283	0.000299	CcSEcCtD
Pamidronate—Vomiting—Gemcitabine—kidney cancer	0.00028	0.000296	CcSEcCtD
Pamidronate—Rash—Gemcitabine—kidney cancer	0.000278	0.000294	CcSEcCtD
Pamidronate—Dermatitis—Gemcitabine—kidney cancer	0.000278	0.000293	CcSEcCtD
Pamidronate—Haemoglobin—Doxorubicin—kidney cancer	0.000276	0.000292	CcSEcCtD
Pamidronate—Headache—Gemcitabine—kidney cancer	0.000276	0.000292	CcSEcCtD
Pamidronate—Nausea—Vincristine—kidney cancer	0.000276	0.000292	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000276	0.000291	CcSEcCtD
Pamidronate—Rhinitis—Doxorubicin—kidney cancer	0.000276	0.000291	CcSEcCtD
Pamidronate—Haemorrhage—Doxorubicin—kidney cancer	0.000275	0.00029	CcSEcCtD
Pamidronate—Insomnia—Capecitabine—kidney cancer	0.000274	0.000289	CcSEcCtD
Pamidronate—Paraesthesia—Capecitabine—kidney cancer	0.000272	0.000287	CcSEcCtD
Pamidronate—Hypersensitivity—Paclitaxel—kidney cancer	0.000272	0.000287	CcSEcCtD
Pamidronate—Urinary tract disorder—Doxorubicin—kidney cancer	0.000271	0.000287	CcSEcCtD
Pamidronate—Connective tissue disorder—Doxorubicin—kidney cancer	0.00027	0.000285	CcSEcCtD
Pamidronate—Dyspnoea—Capecitabine—kidney cancer	0.00027	0.000285	CcSEcCtD
Pamidronate—Urethral disorder—Doxorubicin—kidney cancer	0.000269	0.000284	CcSEcCtD
Pamidronate—Dyspepsia—Capecitabine—kidney cancer	0.000267	0.000282	CcSEcCtD
Pamidronate—Asthenia—Paclitaxel—kidney cancer	0.000265	0.00028	CcSEcCtD
Pamidronate—Decreased appetite—Capecitabine—kidney cancer	0.000263	0.000278	CcSEcCtD
Pamidronate—Nausea—Gemcitabine—kidney cancer	0.000262	0.000277	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000262	0.000276	CcSEcCtD
Pamidronate—Fatigue—Capecitabine—kidney cancer	0.000261	0.000276	CcSEcCtD
Pamidronate—Pruritus—Paclitaxel—kidney cancer	0.000261	0.000276	CcSEcCtD
Pamidronate—Pain—Capecitabine—kidney cancer	0.000259	0.000274	CcSEcCtD
Pamidronate—Constipation—Capecitabine—kidney cancer	0.000259	0.000274	CcSEcCtD
Pamidronate—Eye disorder—Doxorubicin—kidney cancer	0.000257	0.000271	CcSEcCtD
Pamidronate—Flushing—Doxorubicin—kidney cancer	0.000255	0.000269	CcSEcCtD
Pamidronate—Cardiac disorder—Doxorubicin—kidney cancer	0.000255	0.000269	CcSEcCtD
Pamidronate—Diarrhoea—Paclitaxel—kidney cancer	0.000253	0.000267	CcSEcCtD
Pamidronate—Feeling abnormal—Capecitabine—kidney cancer	0.00025	0.000264	CcSEcCtD
Pamidronate—Angiopathy—Doxorubicin—kidney cancer	0.000249	0.000263	CcSEcCtD
Pamidronate—Immune system disorder—Doxorubicin—kidney cancer	0.000248	0.000262	CcSEcCtD
Pamidronate—Gastrointestinal pain—Capecitabine—kidney cancer	0.000248	0.000262	CcSEcCtD
Pamidronate—Mediastinal disorder—Doxorubicin—kidney cancer	0.000248	0.000262	CcSEcCtD
Pamidronate—Chills—Doxorubicin—kidney cancer	0.000247	0.00026	CcSEcCtD
Pamidronate—Dizziness—Paclitaxel—kidney cancer	0.000244	0.000258	CcSEcCtD
Pamidronate—Alopecia—Doxorubicin—kidney cancer	0.000243	0.000256	CcSEcCtD
Pamidronate—Body temperature increased—Capecitabine—kidney cancer	0.00024	0.000253	CcSEcCtD
Pamidronate—Abdominal pain—Capecitabine—kidney cancer	0.00024	0.000253	CcSEcCtD
Pamidronate—Erythema—Doxorubicin—kidney cancer	0.000239	0.000253	CcSEcCtD
Pamidronate—Malnutrition—Doxorubicin—kidney cancer	0.000239	0.000253	CcSEcCtD
Pamidronate—Tension—Doxorubicin—kidney cancer	0.000235	0.000248	CcSEcCtD
Pamidronate—Vomiting—Paclitaxel—kidney cancer	0.000235	0.000248	CcSEcCtD
Pamidronate—Dysgeusia—Doxorubicin—kidney cancer	0.000234	0.000247	CcSEcCtD
Pamidronate—Rash—Paclitaxel—kidney cancer	0.000233	0.000246	CcSEcCtD
Pamidronate—Dermatitis—Paclitaxel—kidney cancer	0.000233	0.000246	CcSEcCtD
Pamidronate—Nervousness—Doxorubicin—kidney cancer	0.000232	0.000245	CcSEcCtD
Pamidronate—Back pain—Doxorubicin—kidney cancer	0.000231	0.000244	CcSEcCtD
Pamidronate—Headache—Paclitaxel—kidney cancer	0.000231	0.000244	CcSEcCtD
Pamidronate—Muscle spasms—Doxorubicin—kidney cancer	0.00023	0.000243	CcSEcCtD
Pamidronate—Hypersensitivity—Capecitabine—kidney cancer	0.000223	0.000236	CcSEcCtD
Pamidronate—Ill-defined disorder—Doxorubicin—kidney cancer	0.000222	0.000234	CcSEcCtD
Pamidronate—Anaemia—Doxorubicin—kidney cancer	0.000221	0.000234	CcSEcCtD
Pamidronate—Agitation—Doxorubicin—kidney cancer	0.00022	0.000232	CcSEcCtD
Pamidronate—Nausea—Paclitaxel—kidney cancer	0.000219	0.000232	CcSEcCtD
Pamidronate—Asthenia—Capecitabine—kidney cancer	0.000217	0.00023	CcSEcCtD
Pamidronate—Malaise—Doxorubicin—kidney cancer	0.000216	0.000228	CcSEcCtD
Pamidronate—Syncope—Doxorubicin—kidney cancer	0.000215	0.000227	CcSEcCtD
Pamidronate—Pruritus—Capecitabine—kidney cancer	0.000214	0.000226	CcSEcCtD
Pamidronate—Leukopenia—Doxorubicin—kidney cancer	0.000214	0.000226	CcSEcCtD
Pamidronate—Loss of consciousness—Doxorubicin—kidney cancer	0.00021	0.000222	CcSEcCtD
Pamidronate—Cough—Doxorubicin—kidney cancer	0.000209	0.00022	CcSEcCtD
Pamidronate—Convulsion—Doxorubicin—kidney cancer	0.000207	0.000219	CcSEcCtD
Pamidronate—Diarrhoea—Capecitabine—kidney cancer	0.000207	0.000219	CcSEcCtD
Pamidronate—Hypertension—Doxorubicin—kidney cancer	0.000207	0.000218	CcSEcCtD
Pamidronate—Myalgia—Doxorubicin—kidney cancer	0.000204	0.000215	CcSEcCtD
Pamidronate—Arthralgia—Doxorubicin—kidney cancer	0.000204	0.000215	CcSEcCtD
Pamidronate—Anxiety—Doxorubicin—kidney cancer	0.000203	0.000214	CcSEcCtD
Pamidronate—Discomfort—Doxorubicin—kidney cancer	0.000201	0.000213	CcSEcCtD
Pamidronate—Dizziness—Capecitabine—kidney cancer	0.0002	0.000212	CcSEcCtD
Pamidronate—Confusional state—Doxorubicin—kidney cancer	0.000197	0.000208	CcSEcCtD
Pamidronate—Anaphylactic shock—Doxorubicin—kidney cancer	0.000195	0.000206	CcSEcCtD
Pamidronate—Oedema—Doxorubicin—kidney cancer	0.000195	0.000206	CcSEcCtD
Pamidronate—Infection—Doxorubicin—kidney cancer	0.000194	0.000205	CcSEcCtD
Pamidronate—Vomiting—Capecitabine—kidney cancer	0.000193	0.000203	CcSEcCtD
Pamidronate—Shock—Doxorubicin—kidney cancer	0.000192	0.000203	CcSEcCtD
Pamidronate—Nervous system disorder—Doxorubicin—kidney cancer	0.000192	0.000202	CcSEcCtD
Pamidronate—Thrombocytopenia—Doxorubicin—kidney cancer	0.000191	0.000202	CcSEcCtD
Pamidronate—Rash—Capecitabine—kidney cancer	0.000191	0.000202	CcSEcCtD
Pamidronate—Dermatitis—Capecitabine—kidney cancer	0.000191	0.000202	CcSEcCtD
Pamidronate—Tachycardia—Doxorubicin—kidney cancer	0.000191	0.000201	CcSEcCtD
Pamidronate—Headache—Capecitabine—kidney cancer	0.00019	0.0002	CcSEcCtD
Pamidronate—Hyperhidrosis—Doxorubicin—kidney cancer	0.000189	0.000199	CcSEcCtD
Pamidronate—Anorexia—Doxorubicin—kidney cancer	0.000186	0.000197	CcSEcCtD
Pamidronate—Hypotension—Doxorubicin—kidney cancer	0.000183	0.000193	CcSEcCtD
Pamidronate—Nausea—Capecitabine—kidney cancer	0.00018	0.00019	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000178	0.000188	CcSEcCtD
Pamidronate—Insomnia—Doxorubicin—kidney cancer	0.000177	0.000186	CcSEcCtD
Pamidronate—Paraesthesia—Doxorubicin—kidney cancer	0.000175	0.000185	CcSEcCtD
Pamidronate—Dyspnoea—Doxorubicin—kidney cancer	0.000174	0.000184	CcSEcCtD
Pamidronate—Somnolence—Doxorubicin—kidney cancer	0.000174	0.000183	CcSEcCtD
Pamidronate—Dyspepsia—Doxorubicin—kidney cancer	0.000172	0.000182	CcSEcCtD
Pamidronate—Decreased appetite—Doxorubicin—kidney cancer	0.00017	0.000179	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000169	0.000178	CcSEcCtD
Pamidronate—Fatigue—Doxorubicin—kidney cancer	0.000168	0.000178	CcSEcCtD
Pamidronate—Pain—Doxorubicin—kidney cancer	0.000167	0.000176	CcSEcCtD
Pamidronate—Constipation—Doxorubicin—kidney cancer	0.000167	0.000176	CcSEcCtD
Pamidronate—Feeling abnormal—Doxorubicin—kidney cancer	0.000161	0.00017	CcSEcCtD
Pamidronate—Gastrointestinal pain—Doxorubicin—kidney cancer	0.00016	0.000169	CcSEcCtD
Pamidronate—Body temperature increased—Doxorubicin—kidney cancer	0.000154	0.000163	CcSEcCtD
Pamidronate—Abdominal pain—Doxorubicin—kidney cancer	0.000154	0.000163	CcSEcCtD
Pamidronate—Hypersensitivity—Doxorubicin—kidney cancer	0.000144	0.000152	CcSEcCtD
Pamidronate—Asthenia—Doxorubicin—kidney cancer	0.00014	0.000148	CcSEcCtD
Pamidronate—Pruritus—Doxorubicin—kidney cancer	0.000138	0.000146	CcSEcCtD
Pamidronate—Diarrhoea—Doxorubicin—kidney cancer	0.000134	0.000141	CcSEcCtD
Pamidronate—Dizziness—Doxorubicin—kidney cancer	0.000129	0.000136	CcSEcCtD
Pamidronate—Vomiting—Doxorubicin—kidney cancer	0.000124	0.000131	CcSEcCtD
Pamidronate—Rash—Doxorubicin—kidney cancer	0.000123	0.00013	CcSEcCtD
Pamidronate—Dermatitis—Doxorubicin—kidney cancer	0.000123	0.00013	CcSEcCtD
Pamidronate—Headache—Doxorubicin—kidney cancer	0.000122	0.000129	CcSEcCtD
Pamidronate—Nausea—Doxorubicin—kidney cancer	0.000116	0.000122	CcSEcCtD
